References of "Gomez Bravo, Raquel 50022378"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailSocial Media as an Opportunity for Public Health Interventions: The #Metoo Movement as an Exemplar
Gomez Bravo, Raquel UL; Gomez Bravo, María; Lygidakis, Charilaos UL et al

in Journal of the International Society for Telemedicine and EHealth (2019), 7(e5), 1-7

Background: Social media have been used exponentially and globally, providing a means for billions of users to connect, interact, share opinions and criticise, becoming one of the main channels of ... [more ▼]

Background: Social media have been used exponentially and globally, providing a means for billions of users to connect, interact, share opinions and criticise, becoming one of the main channels of communication for users around the world. One of the most popular free social media networks is Twitter, with more than 100 million active users per day worldwide. Purpose: The aim of this study was to analyse a sample of the public conversations generated, using the hashtag #MeToo, around the topic of sexual abuse on Twitter. Methods: Using social media marketing software, the use of the #MeToo hashtag was analysed over a period of 60 days (14 September 2017 to 13 November of 2017). Results: The #MeToo conversation was mainly in English (79.3%), located in the United States (48.2% of cases), but with global repercussions. The volume of mentions of the #MeToo hashtag was far greater (97.7%), compared with other hashtags related to violence over this period of time, using mostly Twitter (96.2%). Conclusions: These results suggest that it is possible to describe different groups using the social media, and analyse their conversations to identify opportunities for successful public health interventions. If the topic is relevant for the general public, it will generate interest and conversations at the global level, supported by a universal and borderless channel such as Twitter. [less ▲]

Detailed reference viewed: 374 (9 UL)
Full Text
Peer Reviewed
See detailFamily Violence Curricula in Europe (FAVICUE): a cross-sectional descriptive study protocol
Gomez Bravo, Raquel UL; Lygidakis, Charilaos UL; Feder, Gene et al

in BMJ Open (2019), 9

Introduction. Family violence (FV) is a widespread public health problem of epidemic proportions and serious consequences. Doctors may be the first or only point of contact for victims who may be hesitant ... [more ▼]

Introduction. Family violence (FV) is a widespread public health problem of epidemic proportions and serious consequences. Doctors may be the first or only point of contact for victims who may be hesitant or unable to seek other sources of assistance, and they tend not to disclose abuse to doctors if not specifically asked. A comprehensive healthcare response is key to a coordinated community-wide approach to FV, but most of the practising physicians have received either no or insufficient education or training in any aspect of FV. Training of medical students concerning FV is often delivered in an inconsistent or ad hoc manner. The main aim of this project, Family Violence Curricula in Europe (FAVICUE), is to (1) describe current FV education delivery in European medical universities (undergraduate period) and during the specialist training in general practice (GP)/family medicine (FM) (postgraduate residency programme), and (2) compare it with WHO recommendations for FV curriculum. Methods and analysis. This is the protocol of a cross-sectional descriptive study consisting of two self-report online surveys (for undergraduate and postgraduate training, respectively) with 40 questions each. For both surveys, general practitioners, residents, medical students and professionals involved in their education from countries of the European region will be identified through the European Regional Branch of the World Organization of National Colleges, Academies and Academic Associations of General Practitioners/Family Physicians (WONCA Europe) and will be invited to provide information regarding the training on FV. Descriptive tests will be carried out and a thematic analysis will be conducted on the open-ended questions. Ethics and dissemination Ethics approval has been obtained by the University of Luxembourg (ERP 17–015 FAVICUE). The results will provide important information concerning current curricula on FV, and can be used for mapping the educational needs and planning the implementation of future training interventions. They will be published and disseminated through WONCA Europe and its networks. [less ▲]

Detailed reference viewed: 145 (11 UL)
Full Text
Peer Reviewed
See detailDefining feasibility of Primary care strategies to disclose, counsel and provide access to advocacy on family violence.
Pas; Gomez Bravo, Raquel UL; Clavería, Ana et al

in Collins, Claire (Ed.) Abstract Book of the 87th EGPRN Meeting (2018, November 14)

Background: Family violence (FV) is a widespread public health problem and serious consequences. One third of European women suffer from partner violence in their adult lifetime while on fourth of ... [more ▼]

Background: Family violence (FV) is a widespread public health problem and serious consequences. One third of European women suffer from partner violence in their adult lifetime while on fourth of situations of partner violence children are present. Elderly abuse is present between 10 to 20 % of the population above 60 General practice is often a point of contact for victims but they tend to hesitate or feel ashamed to ask for assistance. GPs generally lack training in disclosing and supporting FV, feel uncomfortable about asking and may be hindered by lack of facilities where to refer. In 2018, WONCA encourages all national colleges and academies to develop policy and implementation strategies on family violence identification and response for intimate partner violence, child abuse and elder abuse. This recommendation states it is needed to develop research and define performance and outcome measures for general practitioners/family doctors and primary care teams in each of our member nations; implementation strategies for comprehensive family violence care should be enabled and evaluated. Research questions: To define needs and concerns of practice teams and analyze possibilities for practice management across European Countries. Method: A Delphi approach modified according to RAND is proposed to develop a consensus using online collection of data. A steering group will be composed of delegates recruited form EGPRN and EUROPREV members to constitute a nominal group validating questions and authorising feedback to respondents for each Delphi round. Country representatives in the project will select a representative sample in each country to allow for generalisability of conclusions per country and European wise. Collaboration with national colleges is encouraged. A meeting at EGPRN in October 2018 will further detail the methodology. A constant comparative methodology using computer software (eg. NVIVO or similar) will be followed analysing data on each question highlighting similarities and differences between answers thus constructing an underlying model about concerns and possible solutions proposed. Points for discussion: How to constitute a sample per country to allow for generalisability. What are main focuses for consensus development? [less ▲]

Detailed reference viewed: 41 (2 UL)
Full Text
Peer Reviewed
See detailAn international case-vignette study to assess general practitioners’ willingness to deprescribe (LESS)
Tabea Jungo, Katharina; Mantelli, Sophie; Rozsnyai, Zsofia et al

in Collins, Claire (Ed.) Abstract Book of the 87th EGPRN Meeting (2018, November 14)

Background: Globally, many oldest-old (>80 years of age) suffer from several chronic conditions and take multiple medications. Ideally, their general practitioners (GPs) regularly and systematically ... [more ▼]

Background: Globally, many oldest-old (>80 years of age) suffer from several chronic conditions and take multiple medications. Ideally, their general practitioners (GPs) regularly and systematically search for inappropriate medications and, if necessary, deprescribe those. However, deprescribing is challenging due to numerous barriers not only within patients, but also within GPs. Research questions: How does the willingness to deprescribe in oldest-old with polypharmacy differ in GPs from different countries? What factors do GPs in different contexts perceive as important for deprescribing? Method: We assess GPs' willingness to deprescribe and the factors GPs perceive to influence their deprescribing decisions in a cross-sectional survey using case-vignettes of oldest-old patients with polypharmacy. We approach GPs in 28 European countries as well as in Israel, Brazil and New Zealand through national coordinators, who administer the survey in their GP network. The case vignettes differ in how dependent patients are and whether or not they have a history of cardiovascular disease (CVD). For each case vignette, GPs are asked if and which medication they would deprescribe. GPs further rate to what extent pre-defined factors influence their deprescribe decisions. We will compare the willingness to deprescribe and the factors influencing deprescribing across countries. Multilevel models will be used to analyze the proportions of the deprescribed medications per case along the continuum of dependency and history of CVD and to analyze the factors perceived as influencing deprescribing decisions. Results: As of early-July 2018, the survey has been distributed in 14 countries and >650 responses have been returned. We will present first results at the conference. Conclusions: First, assessing GPs’ willingness to deprescribe and comparing the factors influencing GPs’ deprescribing decisions across countries will allow an understanding of the expected variation in the willingness to deprescribe across different contexts. Second, it will enable the tailoring of specific interventions that might facilitate deprescribing in oldest-old patients. Points for discussion: How can we explain differences across countries? How can the results be translated into practice in order to help GPs to optimize deprescribing practices? What factors could help GPs to implement deprescribing in oldest-old patients with polypharmacy? [less ▲]

Detailed reference viewed: 40 (2 UL)
Full Text
Peer Reviewed
See detailUsing social media to disseminate primary care research
Lygidakis, Charilaos UL; Gomez Bravo, Raquel UL

in Goodyear-Smith, Felicity; Mash, Robert (Eds.) How To Do Primary Care Research (2018)

Social media are a powerful means of communication among health-care professionals, patients and the public. Their use has been increasing steadily globally, transforming the way that people exchange ... [more ▼]

Social media are a powerful means of communication among health-care professionals, patients and the public. Their use has been increasing steadily globally, transforming the way that people exchange information, interact and collaborate. Physicians are using more and more social networks to connect with broader audiences, communicate with their patients and their colleagues and build a network of trustworthy peers. Researchers are also leveraging social media, capitalising on the velocity with which the messages can spread and the ability to disseminate their messages to the general public in addition to research communities, thus attracting more attention and increasing the influence and impact of their work. [less ▲]

Detailed reference viewed: 77 (13 UL)
Full Text
Peer Reviewed
See detailBurden of cardiovascular disease across 29 countries and GPs’ decision to treat hypertension in oldest-old
Streit, Sven; Gussekloo, Jacobijn; Burman, Robert A. et al

in Scandinavian Journal of Primary Health Care (2018)

Objectives: We previously found large variations in general practitioner (GP) hypertension treatment probability in oldest-old (>80 years) between countries. We wanted to explore whether differences in ... [more ▼]

Objectives: We previously found large variations in general practitioner (GP) hypertension treatment probability in oldest-old (>80 years) between countries. We wanted to explore whether differences in country-specific cardiovascular disease (CVD) burden and life expectancy could explain the differences. Design: This is a survey study using case-vignettes of oldest-old patients with different comorbidities and blood pressure levels. An ecological multilevel model analysis was performed. Setting: GP respondents from European General Practice Research Network (EGPRN) countries, Brazil and New Zeeland. Subjects: This study included 2543 GPs from 29 countries. Main outcome measures: GP treatment probability to start or not start antihypertensive treatment based on responses to case-vignettes; either low (<50% started treatment) or high (!50% started treatment). CVD burden is defined as ratio of disability-adjusted life years (DALYs) lost due to ischemic heart disease and/or stroke and total DALYs lost per country; life expectancy at age 60 and prevalence of oldest-old per country. Results: Of 1947 GPs (76%) responding to all vignettes, 787 (40%) scored high treatment probability and 1160 (60%) scored low. GPs in high CVD burden countries had higher odds of treatment probability (OR 3.70; 95% confidence interval (CI) 3.00–4.57); in countries with low life expectancy at 60, CVD was associated with high treatment probability (OR 2.18, 95% CI 1.12–4.25); but not in countries with high life expectancy (OR 1.06, 95% CI 0.56–1.98). Conclusions: GPs’ choice to treat/not treat hypertension in oldest-old was explained by differences in country-specific health characteristics. GPs in countries with high CVD [less ▲]

Detailed reference viewed: 105 (4 UL)
Full Text
Peer Reviewed
See detailFORMACIÓN SANITARIA EN VIOLENCIA DE GÉNERO. HERRAMIENTAS ONLINE PARA LA CAPACITACIÓN Y TRANSFERENCIA PRÁCTICA
Fernández Alonso, Carmen; Gomez Bravo, Raquel UL; Herrero Velázquez, Sonia et al

in González López-Valcárcel, Beatriz (Ed.) XVII CONGRESO SESPAS XXXV REUNIÓN CIENTÍFICA DE LA SOCIEDAD ESPAÑOLA DE EPIDEMIOLOGÍA Y XII CONGRESSO DA ASSOCIAÇÃO PORTUGUESA DE EPIDEMIOLOGIA XXXVII JORNADAS DE ECONOMÍA DE LA SALUD Ciencia para la Acción (2017, September)

Antecedentes/Objetivos: La formación en VG de los y las profesionales de la salud es una necesidad incuestionable y urgente. De poco sirven las recomendaciones de actuación para la detección de casos y ... [more ▼]

Antecedentes/Objetivos: La formación en VG de los y las profesionales de la salud es una necesidad incuestionable y urgente. De poco sirven las recomendaciones de actuación para la detección de casos y para la atención a las victimas si no disponemos de profesionales formados para llevarlo a cabo. La violencia contra la mujer no está presente en los contenidos curriculares de la mayor parte de las profesiones sanitarias. Por ello la formación en VG supone en muchos casos partir de cero. Supone sensibilizar y convencer que se trata de un problema de salud y nos compete, y luego de capacitar al profesional para una práctica adecuada. Objetivo del estudio: Identificar necesidades de formación de los y las profesionales en VG, los contenidos básicos y los métodos mejor valorados Elaborar un kit de herramientas de ayuda para la formación dirigido a formadores/as en VG. Métodos: Compartir experiencias formativas de 4 organizaciones europeas que trabajan en VG. Análisis de la práctica formativa, diseñar, consensuar y evaluar las herramientas de ayuda a la formación en VG. Resultados: 1. Kit de 28 herramientas para las distintas fases de la formación (preparación, desarrollo, aplicación, seguimiento y evaluación) con ejemplos que facilitan su aplicación práctica. 2. Documento que recoge las herramientas y materiales disponibles para los docentes y discentes. 3. Página web con todo el material (Toolkik) en inglés y en español accesible: www.toolner.com. En 18 meses ha tenido 40.000 visitas 1ª evaluación de una actividad formativa siguiendo esta metodología ha mejorado los conocimientos y actitudes del alumnado. Conclusiones/Recomendaciones: Esta herramienta on-line puede facilitar el trabajo a los formadores/as y contribuir a la mejora de la capacitación de profesionales y la transferencia a la práctica Se trata de una herramienta dinámica que permite realizar cambios y adaptarse a distintos perfiles y necesidades. Accesible en abierto para cualquier usuario. Financiación: Lifelong Learning Programme, acción Leonardo da Vinci (2013-1-DE2-LEO04-16120 4). [less ▲]

Detailed reference viewed: 141 (4 UL)
Full Text
Peer Reviewed
See detailVariation in GP decisions on antihypertensive treatment in oldest-old and frail individuals across 29 countries
Streit, Sven; Verschoor, Marjolein; Rodondi, Nicolas et al

in BMC Geriatrics (2017)

Background In oldest-old patients (>80), few trials showed efficacy of treating hypertension and they included mostly the healthiest elderly. The resulting lack of knowledge has led to inconsistent ... [more ▼]

Background In oldest-old patients (>80), few trials showed efficacy of treating hypertension and they included mostly the healthiest elderly. The resulting lack of knowledge has led to inconsistent guidelines, mainly based on systolic blood pressure (SBP), cardiovascular disease (CVD) but not on frailty despite the high prevalence in oldest-old. This may lead to variation how General Practitioners (GPs) treat hypertension. Our aim was to investigate treatment variation of GPs in oldest-olds across countries and to identify the role of frailty in that decision. Methods Using a survey, we compared treatment decisions in cases of oldest-old varying in SBP, CVD, and frailty. GPs were asked if they would start antihypertensive treatment in each case. In 2016, we invited GPs in Europe, Brazil, Israel, and New Zealand. We compared the percentage of cases that would be treated per countries. A logistic mixed-effects model was used to derive odds ratio (OR) for frailty with 95% confidence intervals (CI), adjusted for SBP, CVD, and GP characteristics (sex, location and prevalence of oldest-old per GP office, and years of experience). The mixed-effects model was used to account for the multiple assessments per GP. Results The 29 countries yielded 2543 participating GPs: 52% were female, 51% located in a city, 71% reported a high prevalence of oldest-old in their offices, 38% and had >20 years of experience. Across countries, considerable variation was found in the decision to start antihypertensive treatment in the oldest-old ranging from 34 to 88%. In 24/29 (83%) countries, frailty was associated with GPs’ decision not to start treatment even after adjustment for SBP, CVD, and GP characteristics (OR 0.53, 95%CI 0.48–0.59; ORs per country 0.11–1.78). Conclusions Across countries, we found considerable variation in starting antihypertensive medication in oldest-old. The frail oldest-old had an odds ratio of 0.53 of receiving antihypertensive treatment. Future hypertension trials should also include frail patients to acquire evidence on the efficacy of antihypertensive treatment in oldest-old patients with frailty, with the aim to get evidence-based data for clinical decision-making. [less ▲]

Detailed reference viewed: 133 (2 UL)
See detailOnline Toolkit: Improving Transfer of Learning into Practice from Training Courses on Violence against Women.
Gomez Bravo, Raquel UL; Fernández Alonso, Carmen; Herrero Velázquez, Sonia et al

(2016, April)

Detailed reference viewed: 90 (15 UL)